$337M | ||
$259M | ||
$79M | ||
$76M | ||
$60M | ||
$57M |
Buys | $524,992 | 2 | 100 |
Sells | $0 | 0 | 0 |
SAUNDERS BRENT L | CEO and Chairman of the Board | 1 | $505,067 | 0 | $0 | $505,067 |
VON ESCHENBACH ANDREW C. | director | 1 | $19,925 | 0 | $0 | $19,925 |
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.
Over the last 12 months, insiders at Bausch + Lomb Corporation have bought $524,992 and sold $0 worth of Bausch + Lomb Corporation stock.
On average, over the past 5 years, insiders at Bausch + Lomb Corporation have bought $524,992 and sold $674.53M worth of stock each year.
Highest buying activity among insiders over the last 12 months: SAUNDERS BRENT L (CEO and Chairman of the Board) — $505,067. VON ESCHENBACH ANDREW C. (director) — $19,925.
The last purchase of 1,695 shares for transaction amount of $19,925 was made by VON ESCHENBACH ANDREW C. (director) on 2025‑05‑02.
2025-05-02 | VON ESCHENBACH ANDREW C. | director | 1,695 0.0005% | $11.76 | $19,925 | -1.04% | ||
2024-08-05 | SAUNDERS BRENT L | CEO and Chairman of the Board | 32,250 0.0093% | $15.66 | $505,067 | +10.13% | ||
2022-06-01 | Sale | Bausch Health Companies Inc. | 9.1M 2.724% | $17.05 | $155.21M | -1.47% | ||
2022-05-10 | Sale | Bausch Health Companies Inc. | 70M 19.4359% | $17.05 | $1.19B | -8.60% |
Increased Positions | 61 | +42.66% | 9M | +22.94% |
Decreased Positions | 63 | -44.06% | 7M | -19.49% |
New Positions | 30 | New | 6M | New |
Sold Out Positions | 29 | Sold Out | 3M | Sold Out |
Total Postitions | 141 | -1.4% | 39M | +3.46% |
Icahn Carl C | $40,250.00 | 0.99% | 3.5M | 0 | 0% | 2024-12-31 |
Maple Rock Capital Partners Inc. | $36,467.00 | 0.9% | 3.17M | -446,495 | -12.34% | 2024-12-31 |
Alberta Investment Management Corp | $34,594.00 | 0.85% | 3.01M | +796,400 | +36.01% | 2024-12-31 |
D. E. Shaw & Co., Inc. | $21,672.00 | 0.53% | 1.88M | -29,750 | -1.55% | 2024-12-31 |
Goldentree Asset Management Lp | $19,920.00 | 0.49% | 1.73M | -2M | -48.38% | 2024-12-31 |
River Road Asset Management, Llc | $17,330.00 | 0.43% | 1.51M | -513,428 | -25.41% | 2024-12-31 |
Whitebox Advisors Llc | $16,596.00 | 0.41% | 1.44M | +199,856 | +16.07% | 2024-12-31 |
Nomura Holdings Inc | $14,446.00 | 0.36% | 1.26M | 0 | 0% | 2024-12-31 |
Arrowstreet Capital, Limited Partnership | $14,012.00 | 0.35% | 1.22M | +414,138 | +51.49% | 2024-12-31 |
King Street Capital Management, L.P. | $13,068.00 | 0.32% | 1.14M | +404,256 | +55.22% | 2024-12-31 |